Thrombotic risk factors in primary antiphospholipid syndrome: A 5-Year prospective study

Maurizio Turiel, Piercarlo Sarzi-Puttini, Rossana Peretti, Edoardo Rossi, Fabiola Atzeni, Wendy Parsons, Andrea Doria

Research output: Contribution to journalArticle

Abstract

Background and Purpose - Because thromboembolic events are frequently observed in primary antiphospholipid syndrome (PAPS), we assessed the risk factors for new thrombotic episodes. Methods - Fifty-six PAPS patients (mean age, 37±10 years) were prospectively studied for 5 years. The preliminary Sapporo classification criteria for antiphospholipid syndrome (APS; a medium-high anticardiolipin antibody [aCL] titer and/or a positive lupus anticoagulant [LA] test in the presence of vascular thrombosis and/or pregnancy morbidity) were used to confirm the diagnosis. Thrombotic episodes or pregnancy losses before a diagnosis of PAPS were considered events, and any new disease manifestation other than thrombocytopenia was considered a recurrent event. Only patients with objectively verified thrombotic events were included in the study. Results - Twenty-one new thrombotic events were observed in 15 subjects (26.8%), including 3 (5.4%) who died during the follow-up. The patients with IgG aCL levels of >40 IgG phospholipid unit (GPL-U) showed a higher incidence of new thrombotic events (43.3%) than those with levels of ≤40 GPL-U (7.7%). Univariate analysis identified a history of recurrent clinical events (P=0.004), a highly positive aCL titer (P=0.007), and the presence of cardiac abnormalities (P=0.036) as significant risk factors for new thrombotic events. A multivariate regression model confirmed that an IgG aCL titer of >40 GPL-U was an independent risk factor for thrombosis (odds ratio, 9.17; 95% confidence interval, 1.83 to 46.05). Conclusions - A high IgG aCL titer is the strongest predictor of new thrombotic events in PAPS patients.

Original languageEnglish
Pages (from-to)1490-1494
Number of pages5
JournalStroke
Volume36
Issue number7
DOIs
Publication statusPublished - Jul 2005

Keywords

  • Antiphospholipid syndrome
  • Echocardiography
  • Thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Thrombotic risk factors in primary antiphospholipid syndrome: A 5-Year prospective study'. Together they form a unique fingerprint.

  • Cite this

    Turiel, M., Sarzi-Puttini, P., Peretti, R., Rossi, E., Atzeni, F., Parsons, W., & Doria, A. (2005). Thrombotic risk factors in primary antiphospholipid syndrome: A 5-Year prospective study. Stroke, 36(7), 1490-1494. https://doi.org/10.1161/01.STR.0000170645.40562.09